Researchers say semaglutide, the medication in Ozempic and Wegovy, may help reverse MASH, a progressive liver condition ...

The Italian study showed that patients with HCC resulting from viral infections or fatty liver had significantly higher ...

Nearly twice as many people taking semaglutide stopped their fatty liver disease without further scarring of the organ, ...

Metabolic liver disease might not get as much attention as heart disease or diabetes, but it affects around one in four people worldwide. Once called non-alcoholic fatty liver disease, this condition ...

Metabolic dysfunction-associated steatotic liver disease (MASLD), is the most common form of chronic liver disease worldwide. This study aimed to ...

The diabetes and weight loss drug semaglutide reversed liver scarring and inflammation. It’s among several drugs in the works for the condition MASH.

According to a 2018 article, at least 25 percent of adults have metabolic dysfunction–associated steatotic liver disease (MASLD), previously known as nonalcoholic fatty liver disease.

Obesity and related metabolic disorders, such as hyperlipidemia and non-alcoholic fatty liver disease, have become ...

Obesity and related metabolic disorders, such as hyperlipidemia and non-alcoholic fatty liver disease, have become ...